AR105333A1 - SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAME - Google Patents
SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAMEInfo
- Publication number
- AR105333A1 AR105333A1 ARP160102107A ARP160102107A AR105333A1 AR 105333 A1 AR105333 A1 AR 105333A1 AR P160102107 A ARP160102107 A AR P160102107A AR P160102107 A ARP160102107 A AR P160102107A AR 105333 A1 AR105333 A1 AR 105333A1
- Authority
- AR
- Argentina
- Prior art keywords
- tau
- methods
- hyperphosphoriled
- same
- specific antibodies
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente se relaciona con una clase de anticuerpo monoclonal que se une de forma específica al resto fosforilado de serina 396 en la tau patológica hiperfosforilada (PHF) (pS396), así como a métodos de uso de estas moléculas y sus fragmentos de unión tau en el tratamiento de la enfermedad de Alzheimer y de las taupatías.This is related to a class of monoclonal antibody that specifically binds the phosphorylated moiety of serine 396 in the hyperphosphorylated pathological tau (PHF) (pS396), as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and taupatias.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1512211.2A GB201512211D0 (en) | 2015-07-13 | 2015-07-13 | Agents, uses and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR105333A1 true AR105333A1 (en) | 2017-09-27 |
Family
ID=54013859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102107A AR105333A1 (en) | 2015-07-13 | 2016-07-12 | SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR105333A1 (en) |
| GB (1) | GB201512211D0 (en) |
-
2015
- 2015-07-13 GB GBGB1512211.2A patent/GB201512211D0/en not_active Ceased
-
2016
- 2016-07-12 AR ARP160102107A patent/AR105333A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201512211D0 (en) | 2015-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2018000012A (en) | SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAME | |
| NI201900003A (en) | SPECIFIC ANTIBODIES FOR HYPERPHOSPHORYLATED TAU AND ITS METHODS OF USE | |
| CO2017012974A2 (en) | Tau binding antibodies | |
| CL2017001154A1 (en) | Specific binding molecules for CD73 and uses thereof | |
| MX393066B (en) | AGONIST ANTIBODIES THAT BIND TO HUMAN CD40 AND THEIR USES. | |
| CU24533B1 (en) | ANTIBODIES OR FRAGMENTS THEREOF THAT BIND THYMIC STROMAL LYMPHOPOYETIN (TSLP) AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| CO2017012971A2 (en) | Tau binding antibodies | |
| CU24498B1 (en) | FACTOR XI ANTIBODIES | |
| UA123202C2 (en) | ANTIBODY TO TAU-PROTEIN AND ITS APPLICATION | |
| CL2019002735A1 (en) | Antibodies that bind to steap-1. | |
| CO2019003759A2 (en) | Antibodies that bind to the zika virus envelope protein and uses thereof | |
| CL2017003311A1 (en) | Multispecific binding proteins. | |
| AR113343A1 (en) | MONOCLONAL ANTI-IL-5Ra ANTIBODY | |
| AR105333A1 (en) | SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND METHODS OF USE OF THE SAME | |
| CR20190012A (en) | SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAUY AND ITS METHODS OF USE | |
| AR109258A1 (en) | SPECIFIC ANTIBODIES FOR HYPERPHOSPHORILED TAU AND ITS METHODS OF USE | |
| EA201892570A1 (en) | ANTIBODIES SPECIFIC TO HYPERPHOSPHORILATED TAU PROTEIN AND WAYS OF THEIR APPLICATION |